LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 1235 | 1241 | 4356 | 0.2849 | 0.0025 |
MCF7 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 1235 | 1370 | 4326 | 0.3167 | 0.0589 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1235 | 4292 | 3974 | 1.0800 | 1.0934 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1235 | 3482 | 4070 | 0.8555 | 0.8265 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1235 | 4186 | 4126 | 1.0145 | 1.0166 |
MCF7 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1235 | 3711 | 3974 | 0.9338 | 0.9204 |
MCF7 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1235 | 2788 | 4070 | 0.6850 | 0.6051 |
MCF7 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1235 | 3082 | 4126 | 0.7469 | 0.6912 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 1235 | 3181 | 3974 | 0.8004 | 0.7526 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 1235 | 2543 | 4070 | 0.6248 | 0.5215 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 1235 | 2913 | 4126 | 0.7060 | 0.6373 |
MCF7 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1235 | 3115 | 3974 | 0.7838 | 0.7309 |
MCF7 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1235 | 2443 | 4070 | 0.6002 | 0.4864 |
MCF7 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1235 | 2942 | 4126 | 0.7130 | 0.6466 |
MCF7 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 1235 | 2698 | 3974 | 0.6789 | 0.5895 |
MCF7 | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 1235 | 2652 | 4070 | 0.6515 | 0.5591 |
MCF7 | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 1235 | 3115 | 4126 | 0.7549 | 0.7016 |
MCF7 | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 1235 | 2757 | 3974 | 0.6937 | 0.6100 |
MCF7 | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 1235 | 2466 | 4070 | 0.6058 | 0.4946 |
MCF7 | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 1235 | 2580 | 4126 | 0.6253 | 0.5269 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 1235 | 2598 | 3974 | 0.6537 | 0.5542 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 2 | F06 | 72 | hr | 1235 | 2966 | 4070 | 0.7287 | 0.6639 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 3 | F06 | 72 | hr | 1235 | 3001 | 4126 | 0.7273 | 0.6655 |
MCF7 | MK2206 | 0.12 | uM | LJP6 | 1 | F05 | 72 | hr | 1235 | 2249 | 3974 | 0.5659 | 0.4268 |
MCF7 | MK2206 | 0.12 | uM | LJP6 | 2 | F05 | 72 | hr | 1235 | 2435 | 4070 | 0.5982 | 0.4836 |